Marvin Ira Siegel

Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ.

Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA.

Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada.

Deltanoid Pharmaceuticals, Inc. researches and develops therapies for the treatment of human diseases. The firm's focus is to move therapies in a variety of areas, including renal disease, osteoporosis, vitamin D deficiency, and acne through the drug development process and seek partners for later stage development and commercialization. The company was founded by Margaret Clagett-Dame and Hector F. DeLuca in 1999 and is headquartered in Madison, WI.

GVIC Communications Corp. operates as an information and marketing solutions company. The firm engages in the provision of information and related services through print and digital media. It operates through following segments: Environmental and Property Information, Commodity Information and Community Media. The company was founded in 1990 and is headquartered in Vancouver, Canada.

The American Academy of Allergy, Asthma & Immunology is a medical organization that provides research summaries from the Journal of Allergy and Clinical Immunology and the Journal of Allergy and Clinical Immunology: In Practice. The AAAAI is based in Milwaukee, WI. The non-profit company offers an overview of anaphylaxis symptoms, diagnosis, treatment, and management written and reviewed by leading experts in allergy, asthma, and immunology. The organization has also created a guide to assist with various aspects of running a medical practice.

SpeciGen, Inc. develops an nanotechnology drug delivery platform. The firm offers protein cage nanospheres technology for targeted drug delivery for the treatment of cancer and cardiovascular diseases. The company was founded in 2006 and is headquartered in Burlingame, CA.